Free Shipping On Orders Over $249 ????                                                        

-30%

Dostiheal Tablet

Original price was: $3.50.Current price is: $2.44.

United States dollar ($) - USD
  • United States dollar ($) - USD
  • Indian rupee (₹) - INR
  • Euro (€) - EUR
  • Australian dollar ($) - AUD
  • Pound sterling (£) - GBP
  • Japanese yen (¥) - JPY

Content: Cabergoline
MAC: Healing Pharma

SKU: N/A Category:

Description

Dostiheal Tablet – Effective Therapy for Prolactin Control & Reproductive Health

At Aksharlifescience.com, we supply genuine Dostiheal Tablet, a dopamine agonist medication containing Cabergoline. It is widely prescribed for the management of elevated prolactin levels and related hormonal disorders, helping restore normal endocrine function and reproductive health in both men and women.

Active Component: Cabergoline (available in 0.25 mg / 0.5 mg strengths)

📋 Product Profile

Therapeutic Class:
Dopamine Agonist / Hormonal Therapy

Indication:
Hyperprolactinemia & Prolactin-Related Disorders

Dosage Form:
Oral Tablet

Strengths Available:
0.25 mg, 0.5 mg

 

🎯 Primary Indications

Dostiheal Tablet is used for:

  • Hyperprolactinemia: Helps reduce elevated prolactin levels
  • Prolactinoma: Assists in shrinking prolactin-secreting pituitary tumors
  • Infertility (Hormonal Causes): May help restore ovulation and fertility in selected patients
  • Amenorrhea: Supports normalization of menstrual cycles
  • Galactorrhea: Helps control inappropriate milk secretion

⚙️ Mechanism of Action

Cabergoline acts as a dopamine receptor agonist:

  • Dopamine Receptor Activation: Stimulates dopamine receptors in the pituitary gland
  • Prolactin Suppression: Inhibits prolactin secretion
  • Tumor Size Reduction: May reduce the size of prolactin-secreting tumors
  • Hormonal Balance: Helps restore normal endocrine and reproductive function

💊 Administration & Dosage

  • Prescription Only: Use under medical supervision
  • Route: Oral tablet
  • Typical Dosage: Usually 0.25 mg to 1 mg per week, divided as prescribed
  • Administration Tip: Take with food to reduce gastrointestinal discomfort
  • Monitoring: Regular prolactin level assessment is recommended

⚠️ Safety & Precautions

Condition Guidance
Medical History Inform doctor about heart valve disorders, liver disease, or hypertension
Cardiac Monitoring Long-term use may require echocardiographic evaluation
Pregnancy Use only if prescribed
Drug Interactions Avoid with dopamine antagonists and certain antihypertensives
Driving/Activities Avoid if experiencing dizziness or lightheadedness

 

🔍 Potential Side Effects

Common and usually mild:

Nausea, headache, dizziness, fatigue

Constipation or abdominal discomfort

Postural hypotension (low blood pressure on standing)

Less common:

  • Mood or behavioral changes

Serious (seek immediate medical attention):

  • Chest pain
  • Breathing difficulty
  • Swelling in legs (possible cardiac-related effects)

 

📦 Storage Instructions

  • Store below 25°C
  • Protect from light and moisture
  • Keep in original packaging
  • Keep out of reach of children

 

⚠️ Medical Disclaimer

Dostiheal Tablet is a prescription medication intended for the management of prolactin-related hormonal disorders. The information provided is for educational purposes only and does not substitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting therapy.

 

🌐 Why Choose Akshar Lifescience?

💊 Genuine, high-quality hormonal medicines

🚀 Fast & trackable worldwide shipping

🌍 Trusted global pharmaceutical exporter

🔐 Secure and discreet packaging

🩺 Expert support for prescription medicines

✅ Order Dostiheal Tablet Today

Manage prolactin-related conditions effectively with Dostiheal Tablet (Cabergoline). A trusted option for restoring hormonal balance and supporting reproductive health.

Akshar Lifescience – Your Trusted Partner in Global Healthcare

There are no reviews yet.

Be the first to review “Dostiheal Tablet”

Your email address will not be published. Required fields are marked *